Healthia Management
Management criteria checks 3/4
Healthia's CEO is Wes Coote, appointed in Apr 2019, has a tenure of 4.67 years. total yearly compensation is A$660.60K, comprised of 60.2% salary and 39.8% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth A$3.58M. The average tenure of the management team and the board of directors is 1.4 years and 5.6 years respectively.
Key information
Wes Coote
Chief executive officer
AU$660.6k
Total compensation
| CEO salary percentage | 60.2% |
| CEO tenure | 4.7yrs |
| CEO ownership | 1.4% |
| Management average tenure | 1.4yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | AU$661k | AU$398k | AU$5m |
| Mar 31 2023 | n/a | n/a | AU$3m |
| Dec 31 2022 | n/a | n/a | AU$781k |
| Sep 30 2022 | n/a | n/a | -AU$1m |
| Jun 30 2022 | AU$516k | AU$345k | -AU$3m |
| Mar 31 2022 | n/a | n/a | -AU$2m |
| Dec 31 2021 | n/a | n/a | AU$161k |
| Sep 30 2021 | n/a | n/a | AU$3m |
| Jun 30 2021 | AU$400k | AU$306k | AU$5m |
| Mar 31 2021 | n/a | n/a | AU$6m |
| Dec 31 2020 | n/a | n/a | AU$7m |
| Sep 30 2020 | n/a | n/a | AU$5m |
| Jun 30 2020 | AU$313k | AU$225k | AU$3m |
| Mar 31 2020 | n/a | n/a | AU$1m |
| Dec 31 2019 | n/a | n/a | AU$271k |
| Sep 30 2019 | n/a | n/a | -AU$483k |
| Jun 30 2019 | AU$226k | AU$176k | -AU$1m |
Compensation vs Market: Wes's total compensation ($USD439.40K) is below average for companies of similar size in the Australian market ($USD641.34K).
Compensation vs Earnings: Wes's compensation has been consistent with company performance over the past year.
CEO
Wes Coote
4.7yrs
Tenure
AU$660,599
Compensation
Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
| Group Chief Financial Officer | less than a year | AU$319.83k | no data | |
| Director of Podiatry & Executive Director | no data | AU$115.34k | 6.4% A$ 16.1m | |
| Group Chief Partnerships Officer & Executive Director | less than a year | AU$391.84k | 0.75% A$ 1.9m | |
| CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
| Chief Executive Officer of Bodies | less than a year | AU$314.24k | no data | |
| Chief Technology Officer | 1.9yrs | AU$261.49k | 2.49% A$ 6.3m | |
| General Counsel & Company Secretary | 1.8yrs | no data | no data | |
| Group Chief Business Development & Strategy Officer | no data | AU$341.32k | 0% A$ 0 | |
| Group Chief Education & Research Officer | no data | no data | no data | |
| Chief Operating Officer of Eyes & Ears Division | less than a year | no data | no data |
1.4yrs
Average Tenure
Experienced Management: HLA's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
| Director of Podiatry & Executive Director | 5.6yrs | AU$115.34k | 6.4% A$ 16.1m | |
| Group Chief Partnerships Officer & Executive Director | 1.7yrs | AU$391.84k | 0.75% A$ 1.9m | |
| CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
| Non-Executive Chairman | 5.6yrs | AU$130.00k | 5.67% A$ 14.3m | |
| Independent Non-Executive Director | 5.6yrs | AU$80.00k | 2.51% A$ 6.3m | |
| Independent Non-Executive Director | 5.6yrs | AU$80.00k | 0.034% A$ 85.2k |
5.6yrs
Average Tenure
Experienced Board: HLA's board of directors are considered experienced (5.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/04 21:07 |
| End of Day Share Price | 2023/11/30 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healthia Limited is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Warren Jeffries | Canaccord Genuity |
| Wilson Wong | Jarden Limited |